SELLAS Life Sciences Group, Inc.SLSNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank43
3Y CAGR-15.0%
5Y CAGR+28.6%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
-15.0%/yr
vs +46.4%/yr prior
5Y CAGR
+28.6%/yr
Recent deceleration
Acceleration
-61.4pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
3.5x
Strong expansion
Streak
1 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 5.80 | -13.7% |
| 2024 | 6.72 | +282.2% |
| 2023 | -3.69 | -139.1% |
| 2022 | 9.44 | +124.3% |
| 2021 | 4.21 | +155.0% |
| 2020 | 1.65 | +32.4% |
| 2019 | 1.25 | -39.3% |
| 2018 | 2.05 | -75.8% |
| 2017 | 8.48 | +363.8% |
| 2016 | 1.83 | - |